BRIEF published on 08/08/2024 at 15:22, 3 months 15 days ago Vanguard Group Discloses Stake in Barratt Developments Securities Transactions Vanguard Group Stake Disclosure Barratt Developments
PRESS RELEASE published on 08/08/2024 at 15:17, 3 months 15 days ago Form 8.3 - The Vanguard Group, Inc.: Barratt Developments plc The Vanguard Group, Inc. discloses 4.94% ownership in Barratt Developments plc securities as of 07 August 2024 Securities Form 8.3 The Vanguard Group Ownership Disclosure Barratt Developments Plc
BRIEF published on 08/07/2024 at 14:45, 3 months 16 days ago Vanguard Group Discloses Position in Barratt Developments Takeover Code Stock Purchase Vanguard Group Public Disclosure Barratt Developments
PRESS RELEASE published on 08/07/2024 at 14:40, 3 months 16 days ago Form 8.3 - The Vanguard Group, Inc.: Barratt Developments plc The Vanguard Group, Inc. discloses 4.94% stake in Barratt Developments plc as of 06 August 2024. Additional disclosure for Redrow plc. Purchase of 10p ordinary securities at 5.12 GBP per unit The Vanguard Group, Inc. Purchase Stake Disclosure Redrow Plc Barratt Developments Plc
BRIEF published on 08/06/2024 at 15:35, 3 months 17 days ago The Vanguard Group, Inc. Discloses Position in Barratt Developments plc Shares Disclosure Takeover Code Vanguard Group Barratt Developments
PRESS RELEASE published on 08/06/2024 at 15:30, 3 months 17 days ago Form 8.3 - The Vanguard Group, Inc.: Barratt Developments plc The Vanguard Group, Inc. discloses holding 4.93% in Barratt Developments plc. Deals in 1 class of relevant securities including purchases at 5.09 GBP per unit Relevant Securities Disclosure The Vanguard Group Inc. Barratt Developments Plc Dealing
BRIEF published on 08/05/2024 at 15:33, 3 months 18 days ago Vanguard Group Discloses Stake in Barratt Developments Plc Form 8.3 Vanguard Group Stake Disclosure Barratt Developments Equity Interests
PRESS RELEASE published on 08/05/2024 at 15:28, 3 months 18 days ago Form 8.3 - The Vanguard Group, Inc.: Barratt Developments plc The Vanguard Group, Inc. discloses 4.93% stake in Barratt Developments plc as of 02 August 2024. Also involved with Redrow plc The Vanguard Group Financial Disclosure Stake Disclosure Redrow Plc Barratt Developments Plc
BRIEF published on 08/01/2024 at 15:17, 3 months 22 days ago Disclosure by The Vanguard Group on Barratt Developments plc Securities Disclosure Vanguard Group Barratt Developments Stakeholding
PRESS RELEASE published on 08/01/2024 at 15:12, 3 months 22 days ago Form 8.3 - The Vanguard Group, Inc.: Barratt Developments plc The Vanguard Group, Inc. discloses a 4.93% stake in Barratt Developments plc as of 31 July 2024. They made purchases and sales of 10p ordinary shares Sales The Vanguard Group, Inc. Stake Disclosure Barratt Developments Plc Purchases
Published on 11/22/2024 at 23:55, 1 day 1 hour ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 1 day 1 hour ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 1 day 2 hours ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 1 day 2 hours ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 1 day 7 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 1 day 7 hours ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 1 day 8 hours ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/21/2024 at 06:58, 2 days 18 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 3 days 5 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 3 days 7 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 3 days 7 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
